<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Basic principles and technique of external electrical cardioversion and defibrillation</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Basic principles and technique of external electrical cardioversion and defibrillation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Basic principles and technique of external electrical cardioversion and defibrillation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bradley P Knight, MD, FACC</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard L Page, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 23, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Electrical cardioversion and defibrillation have become routine procedures in the management of patients with cardiac arrhythmias. Cardioversion is the delivery of energy that is synchronized to the QRS complex, while defibrillation is the nonsynchronized delivery of a shock randomly during the cardiac cycle. In 1956, alternating current (AC) for transthoracic defibrillation was first used to treat ventricular fibrillation in humans [<a href="#rid1">1</a>]. Following this breakthrough, in 1962 direct current (DC) defibrillators were introduced into clinical practice [<a href="#rid2">2</a>]. Subsequent studies in the early 1960s demonstrated that electrical countershock or cardioversion across the closed chest could abolish other cardiac arrhythmias in addition to ventricular fibrillation [<a href="#rid3">3-5</a>].</p><p>This topic will review the basic principles and technique of electrical cardioversion and defibrillation. The clinical indications for these procedures, procedural sedation, potential side effects, and the use of the automated external defibrillator (AED) are discussed separately. (See  <a class="medical medical_review" href="/d/html/983.html" rel="external">"Cardioversion for specific arrhythmias"</a> and  <a class="medical medical_review" href="/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications"</a> and  <a class="medical medical_review" href="/d/html/6330.html" rel="external">"Procedural sedation in children: Approach"</a> and  <a class="medical medical_review" href="/d/html/1042.html" rel="external">"Automated external defibrillators"</a>.)</p><p class="headingAnchor" id="H27614653"><span class="h1">BACKGROUND INFORMATION ON DEFIBRILLATORS</span><span class="headingEndMark"> — </span>Most defibrillators are energy-based, meaning that the devices charge a capacitor to a selected voltage and then deliver a prespecified amount of energy in joules. The amount of energy that arrives at the myocardium is dependent upon the selected voltage and the transthoracic impedance (which varies by patient).</p><p>Two other types of defibrillators are used less frequently in clinical practice:</p><p class="bulletIndent1"><span class="glyph">●</span>Impedance-based defibrillators allow selection of transthoracic current based upon the transthoracic impedance; the latter is assessed initially with a test pulse with the capacitor subsequently charged to the appropriate voltage [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Current-based defibrillation, in which a fixed dose of current is delivered, results in defibrillation thresholds that are independent of transthoracic impedance and are invariant for the individual [<a href="#rid7">7,8</a>]. Defibrillation success for a current-based method is independent of both transthoracic impedance and body weight [<a href="#rid9">9</a>]. Furthermore, this method achieves defibrillation with considerably less energy than does the conventional energy-based method.</p><p></p><p>Defibrillators can also deliver energy in a variety of waveforms, broadly characterized as monophasic or biphasic  (<a class="graphic graphic_figure graphicRef51842" href="/d/graphic/51842.html" rel="external">figure 1</a>). Initially defibrillators delivered only monophasic waveforms. Although monophasic defibrillation is highly effective, biphasic defibrillation terminates arrhythmias more consistently and at lower energy levels. Biphasic defibrillators have largely replaced monophasic defibrillators. (See <a class="local">'Monophasic versus biphasic waveforms'</a> below.) </p><p class="headingAnchor" id="H2"><span class="h1">ELECTROPHYSIOLOGY OF DEFIBRILLATION AND CARDIOVERSION</span><span class="headingEndMark"> — </span>Cardioversion terminates arrhythmias by delivering a synchronized shock that depolarizes the tissue involved in a reentrant circuit  (<a class="graphic graphic_figure graphicRef52134" href="/d/graphic/52134.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef82249" href="/d/graphic/82249.html" rel="external">figure 3</a>). By depolarizing all excitable tissue of the circuit and making the tissue refractory, the circuit is no longer able to propagate or sustain reentry. As a result, cardioversion terminates those arrhythmias resulting from a single reentrant circuit, such as atrial flutter, atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia, or monomorphic ventricular tachycardia. (See  <a class="medical medical_review" href="/d/html/954.html" rel="external">"Reentry and the development of cardiac arrhythmias"</a>.)</p><p>Despite its widespread clinical use, controversy remains concerning the electrophysiologic mechanisms by which electrical cardioversion or defibrillation terminates atrial or ventricular fibrillation, arrhythmias which involve multiple microreentrant circuits. Fibrillation involves the entire atrial or ventricular myocardium and is considered to be a very persistent rhythm. (See  <a class="medical medical_review" href="/d/html/1014.html" rel="external">"The electrocardiogram in atrial fibrillation"</a> and  <a class="medical medical_review" href="/d/html/974.html" rel="external">"Pathophysiology and etiology of sudden cardiac arrest", section on 'Mechanism of ventricular fibrillation'</a>.)</p><p>Most investigators agree that defibrillation occurs when a certain amount of current density reaches the myocardium. However, it is unclear what amount of current density is needed and what energy setting is necessary to achieve a homogeneous current density. At the cellular level, the delivered current flows around and through the myocardial cells, resulting in alteration of the transmembrane potentials [<a href="#rid10">10</a>]. At the organ level, the mechanisms responsible for termination of fibrillation are still controversial [<a href="#rid11">11</a>]. Two explanations have been proposed, which are not necessarily mutually exclusive: the critical mass hypothesis and the upper limit of vulnerability.</p><p class="bulletIndent1"><span class="glyph">●</span>Critical mass hypothesis – There is general agreement that total elimination of fibrillatory activity can be achieved with relatively high defibrillation energy levels [<a href="#rid12">12,13</a>]. According to the critical mass hypothesis, a certain amount of myocardium must be available to sustain atrial or ventricular fibrillation and the entire myocardium must be uniformly depolarized in order to terminate the arrhythmia [<a href="#rid14">14</a>]. Electrophysiological evidence to support this theory has been obtained using a computerized mapping system that recorded simultaneous electrograms from 120 sites [<a href="#rid12">12</a>]. Defibrillation was successful only when fibrillatory activity was annihilated at all sites.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Upper limit of vulnerability hypothesis – According to the upper limit of vulnerability hypothesis, low-energy shocks can induce fibrillation up to a limit where further increases in energy do not induce fibrillation, and the largest shocks that do not induce fibrillation are slightly weaker than necessary for defibrillation [<a href="#rid15">15</a>]. Although shocks abolish small areas of localized reentry during ventricular fibrillation, shocks at strengths below the upper limit of vulnerability stimulate other regions of myocardium during their vulnerable period, giving rise to new areas of local reentry that reinitiate ventricular fibrillation [<a href="#rid16">16-18</a>]. To successfully defibrillate, therefore, the shock strength must be greater than the largest shock that reinitiates fibrillation (the upper limit of vulnerability). This hypothesis is supported by the observation that almost identical changes in the upper limit of vulnerability and the defibrillation threshold occur with changes in electrode polarity and waveform duration [<a href="#rid19">19</a>].</p><p></p><p>Transcardiac shocks of up to 30 joules were delivered to canine myocardial tissue at different times of the cardiac cycle [<a href="#rid20">20</a>]. A shock applied 10 milliseconds before the end of the refractory period extended the refractory period by 63 milliseconds, whereas the same shock given 40 milliseconds earlier produced only a 25-millisecond increase in the refractory period. In contrast, a five-joule shock applied at the same times during the cardiac cycle produced only a 36- and 10-millisecond increase in the refractory period, respectively.</p><p>Because the higher intensity shock selectively extends the refractory period of the myocardium, it may establish a zone of tissue in which repolarization is delayed. This zone is always immediately in front of the newly depolarized tissue, and the inability of the depolarizing impulse to propagate across these refractory zones may be the mechanism responsible for terminating fibrillation. The size of these zones and the duration of increased refractoriness both increase with increasing shock intensity; this may account for the relatively high shock energies required for defibrillation relative to the intensities required to directly depolarize the tissue.</p><p>An electrical shock will also induce different degrees of action potential duration prolongation and dispersion of ventricular repolarization, depending upon shock strength and timing [<a href="#rid21">21</a>]. One study, performed during the post-implantation testing of implantable cardioverter-defibrillators, found that shocks delivered on the T wave generated variable degrees of action potential prolongation, depending upon myocardial repolarization [<a href="#rid22">22</a>]. The creation of high dispersion of repolarization facilitated reentry by creating functional blocks and subsequently favored the induction of ventricular fibrillation and the prevention of its termination by a shock.</p><p>Defibrillation and cardioversion do not appear to cause significant myocardial necrosis [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/d/html/983.html" rel="external">"Cardioversion for specific arrhythmias", section on 'Myocardial necrosis'</a>.)</p><p class="headingAnchor" id="H6"><span class="h1">FACTORS AFFECTING DEFIBRILLATION AND CARDIOVERSION SUCCESS</span><span class="headingEndMark"> — </span>A variety of device-related and patient-related factors will influence the chances of successful cardioversion and/or defibrillation. The device-related variables include factors related to the electrodes (ie, position, size, hand-held versus adhesive patch) and factors related to the energy delivered (ie, number of joules, type of waveform), while the patient-related variables include the transthoracic impedance through which the energy much travel as well as the type and duration of arrhythmia.</p><p class="headingAnchor" id="H2817474"><span class="h2">Device-related variables</span></p><p class="headingAnchor" id="H7"><span class="h3">Electrodes</span><span class="headingEndMark"> — </span>A number of electrode characteristics can affect the outcome of cardioversion. These include electrode position, pad size, and hand-held versus patch electrodes.</p><p class="headingAnchor" id="H8"><span class="h4">Electrode position</span><span class="headingEndMark"> — </span>The placement of defibrillation electrodes on the thorax determines the transthoracic current pathway for external defibrillation. There are two conventional positions for electrode placement  (<a class="graphic graphic_figure graphicRef103268" href="/d/graphic/103268.html" rel="external">figure 4</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Anterolateral orientation </p><p class="bulletIndent1"><span class="glyph">●</span>Anteroposterior orientation</p><p></p><p>In some patients, one (but not the other position) may be effective. As a result, if initial attempts are unsuccessful in terminating the arrhythmia, the electrodes should be relocated to the other position and attempts at defibrillation or cardioversion repeated.</p><p>Several studies have suggested that less energy is required and the success rate is higher with the anteroposterior electrode position in patients cardioverted for atrial fibrillation [<a href="#rid24">24-27</a>]. As an example, in one study of 301 patients, sinus rhythm was restored in 87 percent using an anteroposterior position compared with 76 percent with an anterolateral orientation [<a href="#rid25">25</a>]. In the same study, the mean energy required for successful cardioversion was lower in patients with an anteroposterior electrode position (237 versus 287 joules) [<a href="#rid25">25</a>]. There is also evidence that anteroposterior pad position may be effective in treating refractory ventricular fibrillation [<a href="#rid28">28</a>]. The supporting study is described in detail separately. (See  <a class="medical medical_review" href="/d/html/272.html" rel="external">"Adult basic life support (BLS) for health care providers", section on 'Defibrillation'</a>.) </p><p>However, other reports have failed to confirm these findings and suggest that there is no clear advantage to either electrode configuration [<a href="#rid29">29-31</a>]. In a contemporary randomized trial of patients presenting to the emergency department with acute atrial fibrillation who underwent cardioversion, rates of successful cardioversion to sinus rhythm for at least 30 minutes were similar regardless of electrode position (94 percent with anterolateral placement versus 92 percent with anteroposterior placement) [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H9"><span class="h4">Pad size</span><span class="headingEndMark"> — </span>Electrode pad size is an important determinant of transthoracic current flow during external countershock [<a href="#rid29">29,33-35</a>]. One study analyzed the outcome of cardiac arrests in 105 patients using self-adhesive defibrillator pads of different sizes [<a href="#rid35">35</a>]. A single shock of 200 joules was successful in 31 percent of cardiac arrests using two small pads (each 8 cm in diameter), in 63 percent with one small and one large pad (8 and 12 cm in diameter), and in 82 percent when two large pads (each 12 cm in diameter) were used.</p><p>A larger pad or paddle surface is associated with a decrease in resistance and increase in current and may cause less myocardial necrosis [<a href="#rid36">36-38</a>]. However, there appears to be an optimal electrode size (approximately 12.8 cm) above which any further increase in electrode area causes a decline in current density [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H10"><span class="h4">Hand-held versus patch</span><span class="headingEndMark"> — </span>The use of hand-held paddle electrodes may be more effective than self-adhesive patch electrodes. This was illustrated in a randomized trial of 201 patients referred for cardioversion of persistent atrial fibrillation [<a href="#rid40">40</a>]. Success rates were slightly higher for patients assigned to paddle electrodes (96 versus 88 percent with patch electrodes). Improved electrode-to-skin contact and reduced transthoracic impedance with hand-held electrodes may explain the benefit. </p><p>However, there are no published data comparing hand-held paddle electrodes with self-adhesive patch electrodes for other arrhythmias requiring cardioversion (eg, atrioventricular nodal reentrant tachycardia, atrial flutter) or defibrillation (eg, ventricular fibrillation). Therefore, the decision to use hand-held or self-adhesive electrodes should be made based on the available equipment and the opinion of the operator regarding which electrodes are more likely to be effective for the patient at hand. </p><p class="headingAnchor" id="H11"><span class="h3">Monophasic versus biphasic waveforms</span><span class="headingEndMark"> — </span>Defibrillators can deliver energy in a variety of waveforms that are broadly characterized as monophasic or biphasic. Defibrillators developed prior to 2000 deliver a monophasic wave of direct electrical current. Since then, "biphasic" devices, which reverse current polarity 5 to 10 milliseconds after discharge begins, have been developed  (<a class="graphic graphic_figure graphicRef51842" href="/d/graphic/51842.html" rel="external">figure 1</a>).</p><p>Biphasic waveforms defibrillate more effectively and at lower energies than monophasic waveforms. This benefit has been demonstrated in both animals and humans, and with both ventricular and atrial fibrillation [<a href="#rid41">41-50</a>]. However, monophasic defibrillation is still highly effective in most situations, and it is not clear that the superior efficacy of biphasic defibrillation results in important clinical advantages [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H12"><span class="h4">Ventricular fibrillation</span><span class="headingEndMark"> — </span>Several randomized trials have compared monophasic and biphasic waveforms in the treatment of ventricular fibrillation.</p><p class="bulletIndent1"><span class="glyph">●</span>In the Optimized Response to Cardiac Arrest (ORCA) trial, 115 patients with an out-of-hospital cardiac arrest due to ventricular fibrillation were randomly assigned to defibrillation using a 150 joule biphasic shock or traditional high-energy (200 to 360 joules) monophasic shocks [<a href="#rid46">46</a>]. Successful defibrillation was significantly more likely with biphasic waveforms compared with monophasic waveforms after one shock and total treatment under Emergency Medical Services care (96 versus 59, and 100 versus 84 percent respectively). In addition, the rate of return of spontaneous circulation was higher with biphasic shock therapy (76 versus 54 percent).</p><p></p><p>However, there was no difference in the rate of survival to hospital discharge between the two therapies. Among patients who survived to discharge, those treated with a biphasic shock were more likely to have good cerebral performance (87 versus 53 percent).</p><p class="bulletIndent1"><span class="glyph">●</span>In the Out-of-hospital cardiac arrest rectilinear biphasic to monophasic damped sine defibrillation waveforms with advanced life support intervention trial (ORBIT) of 169 patient with out-of-hospital cardiac arrest, biphasic shocks (escalating 120, 150, or 200 joules) were more effective than monophasic shocks (escalating 200, 300, and 360 joules) as defined by conversion at 5 sec to an organized rhythm (52 versus 34 percent) [<a href="#rid52">52</a>]. However, there were no significant differences in return of spontaneous circulation (47 percent in both groups) or survival to discharge from hospital (9 versus 7 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the Transthoracic Incremental Monophasic versus Biphasic defibrillation by Emergency Responders (TIMBER) trial, 168 patients with an out-of-hospital cardiac arrest due to ventricular fibrillation were randomly assigned to treatment with either monophasic or biphasic defibrillation [<a href="#rid53">53</a>]. Defibrillation was initially performed by Emergency Medical Service with an automated external defibrillator (AED), and if necessary, with a manual defibrillator by paramedics who arrived later. Patients were included only if all shocks were delivered with the same waveform. In contrast to the ORCA trial, in TIMBER the defibrillation energies were the same for both waveforms (200 followed by 200 and then 360 joules).</p><p></p><p>There were no statistically significant differences between the treatment arms with regard to the success of initial shocks, the rate of survival, or neurologic outcomes. However, biphasic defibrillation did result in nonsignificant trends towards earlier return of spontaneous circulation and increased overall survival (41 versus 34 percent, compared with monophasic defibrillation).</p><p>There is no clear explanation for the discrepant findings in these three trials. Due to the complexities and urgencies associated with resuscitation, in combination with the small sample sizes available for controlled studies, it is difficult to demonstrate or exclude important clinical benefits. Based upon the greater efficacy of biphasic defibrillation demonstrated in other settings, the lack of evidence of harm from biphasic defibrillation, and the trends towards outcome benefits suggested by clinical trials, we support the use of biphasic defibrillation for the treatment of ventricular arrhythmias.</p><p class="headingAnchor" id="H13"><span class="h4">Atrial fibrillation</span><span class="headingEndMark"> — </span>The benefit of the biphasic waveform for the treatment of atrial fibrillation has been illustrated in two randomized trials:</p><p class="bulletIndent1"><span class="glyph">●</span>In one trial, 174 patients with AF were randomly assigned to cardioversion with a monophasic waveform, using sequential shocks of 100 to 360 joules, or biphasic waveform, with energies of 70 to 170 joules [<a href="#rid48">48</a>]. First shock efficacy was greater with a biphasic waveform (68 versus 21 percent), delivered energy was 50 percent less, and the overall cardioversion rate was higher (94 versus 79 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Similar benefits were noted in a comparable randomized trial of 210 patients [<a href="#rid49">49</a>]. Biphasic waveforms were associated with the following significant benefits: greater first shock efficacy (60 versus 22 percent); fewer total shocks (1.7 versus 2.8); less energy delivered (217 versus 548 joules), and a lower frequency of dermal injury (17 versus 41 percent).</p><p></p><p>In a larger nonrandomized experience, 2546 patients with AF were cardioverted using a monophasic (1996 to 1999) or biphasic (1999 to 2001) defibrillator [<a href="#rid50">50</a>]. With the biphasic waveform, the overall success of cardioversion was greater (99.1 versus 92.4 percent) and the energy level required for cardioversion was lower (median 100 versus 200 joules).</p><p>Similar findings have been reported for patients with atrial flutter, in whom cardioversion was successful more frequently and at lower energy levels when using biphasic waveforms [<a href="#rid54">54,55</a>]. </p><p class="headingAnchor" id="H14"><span class="h4">Optimal biphasic defibrillation energies</span><span class="headingEndMark"> — </span>Because biphasic shocks are more effective at lower energies than monophasic shocks, initial protocols often suggested using lower-energy biphasic shocks during resuscitation (eg, 150 joules). The value of higher energy biphasic shocks was demonstrated in the BIPHASIC trial [<a href="#rid56">56</a>]. A series of 221 patients with out-of-hospital cardiac arrest were randomly assigned to either fixed lower energy defibrillation (150 joules, followed by up to two additional shocks at the same energy as necessary), or to escalating higher-energy shocks (200 joules, followed by 300 and 360 joule shocks as necessary). Shocks were administered by an AED. The following results were noted:</p><p class="bulletIndent1"><span class="glyph">●</span>The rate of successful defibrillation with the first shock was the same in both groups (37 versus 38 percent in the escalating higher and fixed lower treatment groups, respectively).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among patients requiring multiple shocks (n = 106), patients assigned to the escalating higher-energy protocol were significantly more likely to be successfully cardioverted (37 versus 25 percent, compared with patients assigned to the fixed lower-energy protocol).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There were no significant differences between regimens in adverse events including cardiac enzyme elevation and left ventricular systolic dysfunction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There were no differences between regimens in survival outcomes, although this could be due in part to the relatively small sample size. </p><p></p><p>Based upon the absence of adverse events and the greater efficacy in patients requiring multiple shocks, we agree with the use of escalating higher-energy shocks with biphasic defibrillators in the treatment of cardiac arrest due to a ventricular tachyarrhythmia that does not respond to an initial lower energy shock.</p><p class="headingAnchor" id="H4072367215"><span class="h3">Double sequential external defibrillation</span><span class="headingEndMark"> — </span>Double sequential external defibrillation (DSED) consists of rapid sequential shocks from two defibrillators; this has been shown to be effective at terminating refractory ventricular fibrillation [<a href="#rid28">28</a>]. The supporting study is described in detail separately. (See  <a class="medical medical_review" href="/d/html/272.html" rel="external">"Adult basic life support (BLS) for health care providers", section on 'Defibrillation'</a>.) </p><p>If more studies are supportive of DSED for patients with refractory ventricular fibrillation, this could be a strategy employed in a hospital setting.</p><p class="headingAnchor" id="H2155703"><span class="h2">Patient-related variables</span></p><p class="headingAnchor" id="H15"><span class="h3">Transthoracic impedance</span><span class="headingEndMark"> — </span>To compensate for transthoracic impedance during transthoracic defibrillation, a considerably larger current must be delivered to the thorax than is required for internal defibrillation. Impedance results in the dissipation of energy due to shunting to the lungs, the thoracic cage, and other elements of the chest. In an animal study, 82 percent of the transthoracic current was shunted to the thoracic cage, 14 percent to the lungs, and only 4 percent passed through to the heart [<a href="#rid57">57</a>].</p><p>Transthoracic impedance is determined by multiple factors including:</p><p class="bulletIndent1"><span class="glyph">●</span>Energy level</p><p class="bulletIndent1"><span class="glyph">●</span>Electrode-to-skin interface</p><p class="bulletIndent1"><span class="glyph">●</span>Interelectrode distance</p><p class="bulletIndent1"><span class="glyph">●</span>Electrode pressure (with hand-held electrodes)</p><p class="bulletIndent1"><span class="glyph">●</span>Phase of ventilation</p><p class="bulletIndent1"><span class="glyph">●</span>Myocardial tissue and blood conductive properties</p><p></p><p>In animals, repetitive shocks delivered at three minute intervals decrease the transthoracic impedance to a greater extent than repetitive shocks delivered at 15 or 60 second intervals [<a href="#rid58">58,59</a>]. Similar trends have been reported in humans, but the changes in impedance were not found to be clinically relevant [<a href="#rid59">59,60</a>]. With repeated shocks, impedance decreased by as much as 8 percent and the peak current increased by 4 percent [<a href="#rid61">61</a>]. Therefore, despite only a minimally larger amount of energy being delivered to the heart, an unsuccessful shock should be followed promptly by a higher energy shock.</p><p>An animal study examined the mechanisms responsible for the decline in transthoracic impedance after direct current (DC) shocks [<a href="#rid62">62</a>]. After three 100-joule shocks, there was an 11 percent decline in transthoracic impedance which correlated with a tenfold increase in skeletal muscle blood flow. This observation suggests that tissue edema contributes to the DC shock-induced decline in transthoracic impedance.</p><p>A second report evaluated the effect of prior sternotomy on transthoracic impedance [<a href="#rid63">63</a>]. Transthoracic impedance decreased after sternotomy and remained below preoperative measurements even after wound healing was complete, suggesting that the hyperemia, inflammation, tissue edema, and pleural effusion associated with sternotomy were the major contributors to the reduction in impedance.</p><p>The phase of ventilation is another factor that alters transthoracic impedance. Inspiration (and the increased volume of air within the lungs) is associated with a 13 percent higher transthoracic impedance than expiration [<a href="#rid64">64</a>].</p><p>The composition of the gel used during cardioversion also affects the transthoracic impedance. In a study comparing a non-salt-containing gel with a salt-containing gel, transthoracic impedance was 20 percent higher with the non-salt-containing gel [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H16"><span class="h3">Type of arrhythmia</span><span class="headingEndMark"> — </span>The type of arrhythmia and the patient's clinical condition are important determinants of defibrillation success [<a href="#rid66">66-68</a>]. As an example, patients with ventricular fibrillation as the primary event are easier to defibrillate than patients with secondary ventricular fibrillation resulting from uncompensated congestive heart failure and hypotension.</p><p>The different energy requirements between organized and non-organized arrhythmias may be related to the electrophysiologic characteristics of the arrhythmia. Organized arrhythmias, such as sustained monomorphic ventricular tachycardia, arise from a discrete reentrant circuit which is easily depolarized by smaller amounts of current [<a href="#rid69">69,70</a>]. In contrast, in non-organized rhythms such as polymorphic ventricular tachycardia and ventricular fibrillation, the wavefronts are multiple and involve more myocardial mass, thereby requiring more energy for termination [<a href="#rid18">18</a>].</p><p>The electrical current and energy required to terminate ventricular tachyarrhythmias vary by arrhythmia. Ventricular tachycardia generally requires less energy than ventricular fibrillation. In one study of 203 patients who received 569 shocks for ventricular tachycardia or fibrillation, the heart rate and electrocardiographic degree of organization of the tachycardia were important determinants of transthoracic energy and the current requirements for cardioversion or defibrillation [<a href="#rid71">71</a>]. Transthoracic termination of monomorphic ventricular tachycardia required relatively low energy (70 to 100 joules) while polymorphic ventricular tachycardia required more energy (150 to 200 joules).</p><p>The varying energy requirements for cardioversion for ventricular tachyarrhythmias are analogous to those of atrial tachyarrhythmias. Atrial flutter, a more organized rhythm than atrial fibrillation, generally terminates with lower electrical doses.</p><p class="headingAnchor" id="H17"><span class="h3">Duration of arrhythmia</span><span class="headingEndMark"> — </span>An additional factor in the likelihood of a successful cardioversion or defibrillation, for both ventricular and atrial arrhythmias, is the amount of time an arrhythmia has been present.</p><p class="bulletIndent1"><span class="glyph">●</span>In ventricular fibrillation the duration of the arrhythmia is a determinant of the degree of organization of the electrical impulse. Even when using a biphasic waveform, the effectiveness of defibrillation is reduced when the arrhythmia is of longer duration [<a href="#rid72">72</a>]. The more recent the onset of ventricular fibrillation, the coarser are the fibrillatory waves and the greater the success with defibrillation. As the arrhythmia persists (ie, more than 10 to 30 seconds), the fibrillatory waves become finer and the likelihood of successful termination decreases [<a href="#rid73">73-75</a>].</p><p></p><p class="bulletIndent1">This relationship has also been demonstrated in a study of 22 patients with an implantable cardioverter-defibrillator [<a href="#rid74">74</a>]. Defibrillation was effective in 82 percent of patients when delivered after five seconds compared with 45 percent when delivered after 15 seconds. (See  <a class="medical medical_review" href="/d/html/973.html" rel="external">"Prognosis and outcomes following sudden cardiac arrest in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In atrial fibrillation there is a similar relationship between duration of atrial fibrillation and the success of cardioversion, although longer time periods are usually involved. One study of 198 patients found that sinus rhythm was restored in 98 percent of patients when the duration of atrial fibrillation was less than 24 hours compared with a success rate of 62 percent when the duration was more than 24 hours [<a href="#rid76">76</a>]. The overall success rate for sinus rhythm restoration is approximately 90 percent when atrial fibrillation is of less than one year's duration compared with 50 percent when atrial fibrillation has been present for more than five years [<a href="#rid77">77</a>].</p><p></p><p class="headingAnchor" id="H1667739759"><span class="h3">Use of antiarrhythmic drugs</span><span class="headingEndMark"> — </span>Antiarrhythmic drugs can increase or decrease the defibrillation energy requirements for ventricular fibrillation and the cardioversion energy requirements for atrial fibrillation. In general, sodium channel blockers increase the energy required for defibrillation, while potassium channel blockers and catecholamines decrease the energy needed. For example, <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> increases defibrillation energy requirements, and <a class="drug drug_general" data-topicid="9941" href="/d/drug information/9941.html" rel="external">sotalol</a> and <a class="drug drug_general" data-topicid="8548" href="/d/drug information/8548.html" rel="external">ibutilide</a> decrease the energy needed [<a href="#rid78">78</a>]. Epinephrine's effect on cycle length, synchronization, and dispersion of repolarization of fibrillatory waves may be the mechanisms by which it facilitates defibrillation [<a href="#rid79">79</a>]. These observations are relevant to external defibrillation success in the setting of a cardiac arrest, the ability to successfully defibrillate a patient with an implantable defibrillator during defibrillation threshold testing, and the use of ibutilide to facilitate restoration of sinus rhythm in patients undergoing elective cardioversion for atrial fibrillation [<a href="#rid80">80</a>].</p><p class="headingAnchor" id="H6508517"><span class="h3">Patients with an underlying cardiac implantable electronic device</span><span class="headingEndMark"> — </span>Patients with an underlying cardiac implantable electronic device (CIED) such as a permanent pacemaker or an implantable cardioverter-defibrillator require special attention to electrode placement. In such patients, we recommend placing the external electrode pads in the anteroposterior position and avoiding any contact with the skin overlying the CIED. Positioning of the electrode pads to avoid making contact with the skin overlying the CIED is critical to maximizing the efficacy of the externally delivered shock and minimizing the likelihood of damage to the CIED from the externally delivered shock.</p><p class="headingAnchor" id="H18"><span class="h1">ENERGY SELECTION FOR CARDIOVERSION AND DEFIBRILLATION</span><span class="headingEndMark"> — </span>The amount of energy selected for initial attempts of defibrillation has been controversial. The energy selected should be sufficient to accomplish prompt defibrillation because repeated failures expose the heart to damage from prolonged ischemia and multiple shocks. On the other hand, excessive energy should be avoided, since myocardial damage from high-energy shocks has been demonstrated in experimental studies, although the frequency with which this occurs in humans is not known. The choice of energy for initial attempts at cardioversion or defibrillation is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/983.html" rel="external">"Cardioversion for specific arrhythmias", section on 'Energy selection'</a>.)</p><p class="headingAnchor" id="H2506162387"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/117075.html" rel="external">"Society guideline links: Basic and advanced cardiac life support in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/138311.html" rel="external">"Society guideline links: Cardiac arrest in adults"</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/3435.html" rel="external">"Patient education: Cardioversion (Beyond the Basics)"</a>) </p><p></p><p class="headingAnchor" id="H2817447"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Electrical cardioversion and defibrillation have become routine procedures in the management of patients with cardiac arrhythmias. Cardioversion is the delivery of energy that is synchronized to the QRS complex, while defibrillation is the non-synchronized delivery of a shock during the cardiac cycle. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardioversion terminates arrhythmias by delivering a synchronized shock that depolarizes the tissue involved in a reentrant circuit  (<a class="graphic graphic_figure graphicRef52134" href="/d/graphic/52134.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef82249" href="/d/graphic/82249.html" rel="external">figure 3</a>). By depolarizing all excitable tissue of the circuit and making the tissue refractory, the circuit is no longer able to propagate or sustain reentry. (See <a class="local">'Electrophysiology of defibrillation and cardioversion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Despite its widespread clinical use, controversy persists concerning the electrophysiologic mechanisms by which electrical cardioversion or defibrillation terminates atrial or ventricular fibrillation, arrhythmias which involve multiple microreentrant circuits. Most investigators agree that defibrillation occurs when a certain amount of current density reaches the myocardium. However, it is unclear what amount of current density is needed and what energy setting is necessary to achieve a homogeneous current density. (See <a class="local">'Electrophysiology of defibrillation and cardioversion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A variety of device-related factors will influence the chances of successful cardioversion and/or defibrillation, including electrode size and position, hand-held versus self-adhesive patch electrodes, and monophasic versus biphasic waveforms. (See <a class="local">'Device-related variables'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A variety of patient-related factors also influence the chances of successful cardioversion and/or defibrillation, including transthoracic impedance, type of arrhythmia, use of antiarrhythmic drugs, and the duration of arrhythmia. (See <a class="local">'Patient-related variables'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>While the anteroposterior electrode position is suggested for most patients, for persons with an underlying cardiac implantable electronic device (CIED) such as a permanent pacemaker or an implantable cardioverter-defibrillator, we specifically recommend placing the external electrode pads in the anteroposterior position and avoiding any contact with the skin overlying the CIED. This placement should maximize the shock efficacy and minimize the likelihood of damage to the CIED. (See <a class="local">'Electrode position'</a> above and <a class="local">'Patients with an underlying cardiac implantable electronic device'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">ZOLL PM, LINENTHAL AJ, GIBSON W, et al. Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med 1956; 254:727.</a></li><li><a class="nounderline abstract_t">LOWN B, AMARASINGHAM R, NEUMAN J. New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. JAMA 1962; 182:548.</a></li><li><a class="nounderline abstract_t">ALEXANDER S, KLEIGER R, LOWN B. Use of external electric countershock in the treatment of ventricular tachycardia. JAMA 1961; 177:916.</a></li><li><a class="nounderline abstract_t">Zoll PM, Linentha AJ. Termination of refractory tachycardia by external countershock. Circulation 1962; 25:596.</a></li><li><a class="nounderline abstract_t">PAUL MH, MILLER RA. External electrical termination of supraventricular arrhythmias in congenital heart disease. Circulation 1962; 25:604.</a></li><li><a class="nounderline abstract_t">Kerber RE, Martins JB, Kienzle MG, et al. Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. Circulation 1988; 77:1038.</a></li><li><a class="nounderline abstract_t">Lerman BB, Halperin HR, Tsitlik JE, et al. Relationship between canine transthoracic impedance and defibrillation threshold. Evidence for current-based defibrillation. J Clin Invest 1987; 80:797.</a></li><li><a class="nounderline abstract_t">Kerber RE, Jensen SR, Gascho JA, et al. Determinants of defibrillation: prospective analysis of 183 patients. Am J Cardiol 1983; 52:739.</a></li><li><a class="nounderline abstract_t">Lerman BB, DiMarco JP, Haines DE. Current-based versus energy-based ventricular defibrillation: a prospective study. J Am Coll Cardiol 1988; 12:1259.</a></li><li><a class="nounderline abstract_t">Plonsey R, Barr RC. Effect of microscopic and macroscopic discontinuities on the response of cardiac tissue to defibrillating (stimulating) currents. Med Biol Eng Comput 1986; 24:130.</a></li><li><a class="nounderline abstract_t">Mower MM, Mirowski M, Spear JF, Moore EN. Patterns of ventricular activity during catheter defibrillation. Circulation 1974; 49:858.</a></li><li><a class="nounderline abstract_t">Witkowski FX, Penkoske PA, Plonsey R. Mechanism of cardiac defibrillation in open-chest dogs with unipolar DC-coupled simultaneous activation and shock potential recordings. Circulation 1990; 82:244.</a></li><li><a class="nounderline abstract_t">Chen PS, Shibata N, Dixon EG, et al. Activation during ventricular defibrillation in open-chest dogs. Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks. J Clin Invest 1986; 77:810.</a></li><li><a class="nounderline abstract_t">Zipes DP, Fischer J, King RM, et al. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol 1975; 36:37.</a></li><li><a class="nounderline abstract_t">Chen PS, Wolf PD, Ideker RE. Mechanism of cardiac defibrillation. A different point of view. Circulation 1991; 84:913.</a></li><li><a class="nounderline abstract_t">Witkowski, FX, Kerber, RE . Currently known mechanisms underlying direct current external and internal cardiac defibrillation. J Cardiovasc Electrophysiol 1991; 2:562.</a></li><li><a class="nounderline abstract_t">Chen PS, Shibata N, Dixon EG, et al. Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability. Circulation 1986; 73:1022.</a></li><li><a class="nounderline abstract_t">Chen PS, Wolf PD, Melnick SD, et al. Comparison of activation during ventricular fibrillation and following unsuccessful defibrillation shocks in open-chest dogs. Circ Res 1990; 66:1544.</a></li><li><a class="nounderline abstract_t">Huang J, KenKnight BH, Walcott GP, et al. Effects of transvenous electrode polarity and waveform duration on the relationship between defibrillation threshold and upper limit of vulnerability. Circulation 1997; 96:1351.</a></li><li><a class="nounderline abstract_t">Sweeney RJ, Gill RM, Steinberg MI, Reid PR. Ventricular refractory period extension caused by defibrillation shocks. Circulation 1990; 82:965.</a></li><li><a class="nounderline abstract_t">Zhou XH, Knisley SB, Wolf PD, et al. Prolongation of repolarization time by electric field stimulation with monophasic and biphasic shocks in open-chest dogs. Circ Res 1991; 68:1761.</a></li><li><a class="nounderline abstract_t">Moubarak JB, Karasik PE, Fletcher RD, Franz MR. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation. J Am Coll Cardiol 2000; 35:422.</a></li><li><a class="nounderline abstract_t">Goktekin O, Melek M, Gorenek B, et al. Cardiac troponin T and cardiac enzymes after external transthoracic cardioversion of ventricular arrhythmias in patients with coronary artery disease. Chest 2002; 122:2050.</a></li><li><a class="nounderline abstract_t">Lown B, Kleiger R, Wolff G. THE TECHNIQUE OF CARDIOVERSION. Am Heart J 1964; 67:282.</a></li><li><a class="nounderline abstract_t">Botto GL, Politi A, Bonini W, et al. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart 1999; 82:726.</a></li><li><a class="nounderline abstract_t">Kirchhof P, Eckardt L, Loh P, et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 2002; 360:1275.</a></li><li><a class="nounderline abstract_t">Myerburg RJ, Castellanos A. Electrode positioning for cardioversion of atrial fibrillation. Lancet 2002; 360:1263.</a></li><li><a class="nounderline abstract_t">Cheskes S, Verbeek PR, Drennan IR, et al. Defibrillation Strategies for Refractory Ventricular Fibrillation. N Engl J Med 2022; 387:1947.</a></li><li><a class="nounderline abstract_t">Kerber RE, Jensen SR, Grayzel J, et al. Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements. N Engl J Med 1981; 305:658.</a></li><li><a class="nounderline abstract_t">Mathew TP, Moore A, McIntyre M, et al. Randomised comparison of electrode positions for cardioversion of atrial fibrillation. Heart 1999; 81:576.</a></li><li><a class="nounderline abstract_t">Walsh SJ, McCarty D, McClelland AJ, et al. Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions. Eur Heart J 2005; 26:1298.</a></li><li><a class="nounderline abstract_t">Stiell IG, Sivilotti MLA, Taljaard M, et al. Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial. Lancet 2020; 395:339.</a></li><li><a class="nounderline abstract_t">Thomas ED, Ewy GA, Dahl CF, Ewy MD. Effectiveness of direct current defibrillation: role of paddle electrode size. Am Heart J 1977; 93:463.</a></li><li><a class="nounderline abstract_t">Ewy GA, Horan WJ. Effectiveness of direct current defibrillation: role of paddle electrode size: II. Am Heart J 1977; 93:674.</a></li><li><a class="nounderline abstract_t">Dalzell GW, Cunningham SR, Anderson J, Adgey AA. Electrode pad size, transthoracic impedance and success of external ventricular defibrillation. Am J Cardiol 1989; 64:741.</a></li><li><a class="nounderline abstract_t">Kugelberg J. The interelectrode electrical resistance at defibrillation. Scand J Thorac Cardiovasc Surg 1972; 6:274.</a></li><li><a class="nounderline abstract_t">Ewy GA, Taren D. Impedance to transthoracic direct current discharge: a model for testing interface material. Med Instrum 1978; 12:47.</a></li><li><a class="nounderline abstract_t">Dahl CF, Ewy GA, Warner ED, Thomas ED. Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation 1974; 50:956.</a></li><li><a class="nounderline abstract_t">Hoyt R, Grayzel J, Kerber RE. Determinants of intracardiac current in defibrillation. Experimental studies in dogs. Circulation 1981; 64:818.</a></li><li><a class="nounderline abstract_t">Kirchhof P, Mönnig G, Wasmer K, et al. A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA). Eur Heart J 2005; 26:1292.</a></li><li><a class="nounderline abstract_t">Schuder JC, McDaniel WC, Stoeckle H. Defibrillation of 100 kg calves with asymmetrical, bidirectional, rectangular pulses. Cardiovasc Res 1984; 18:419.</a></li><li><a class="nounderline abstract_t">Walcott GP, Melnick SB, Chapman FW, et al. Relative efficacy of monophasic and biphasic waveforms for transthoracic defibrillation after short and long durations of ventricular fibrillation. Circulation 1998; 98:2210.</a></li><li><a class="nounderline abstract_t">Leng CT, Paradis NA, Calkins H, et al. Resuscitation after prolonged ventricular fibrillation with use of monophasic and biphasic waveform pulses for external defibrillation. Circulation 2000; 101:2968.</a></li><li><a class="nounderline abstract_t">Jones JL, Jones RE. Improved defibrillator waveform safety factor with biphasic waveforms. Am J Physiol 1983; 245:H60.</a></li><li><a class="nounderline abstract_t">Niemann JT, Burian D, Garner D, Lewis RJ. Monophasic versus biphasic transthoracic countershock after prolonged ventricular fibrillation in a swine model. J Am Coll Cardiol 2000; 36:932.</a></li><li><a class="nounderline abstract_t">Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Optimized Response to Cardiac Arrest (ORCA) Investigators. Circulation 2000; 102:1780.</a></li><li><a class="nounderline abstract_t">Mittal S, Ayati S, Stein KM, et al. Comparison of a novel rectilinear biphasic waveform with a damped sine wave monophasic waveform for transthoracic ventricular defibrillation. ZOLL Investigators. J Am Coll Cardiol 1999; 34:1595.</a></li><li><a class="nounderline abstract_t">Mittal S, Ayati S, Stein KM, et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000; 101:1282.</a></li><li><a class="nounderline abstract_t">Page RL, Kerber RE, Russell JK, et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol 2002; 39:1956.</a></li><li><a class="nounderline abstract_t">Niebauer MJ, Brewer JE, Chung MK, Tchou PJ. Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter. Am J Cardiol 2004; 93:1495.</a></li><li><a class="nounderline abstract_t">Faddy SC, Jennings PA. Biphasic versus monophasic waveforms for transthoracic defibrillation in out-of-hospital cardiac arrest. Cochrane Database Syst Rev 2016; 2:CD006762.</a></li><li><a class="nounderline abstract_t">Morrison LJ, Dorian P, Long J, et al. Out-of-hospital cardiac arrest rectilinear biphasic to monophasic damped sine defibrillation waveforms with advanced life support intervention trial (ORBIT). Resuscitation 2005; 66:149.</a></li><li><a class="nounderline abstract_t">Kudenchuk PJ, Cobb LA, Copass MK, et al. Transthoracic incremental monophasic versus biphasic defibrillation by emergency responders (TIMBER): a randomized comparison of monophasic with biphasic waveform ascending energy defibrillation for the resuscitation of out-of-hospital cardiac arrest due to ventricular fibrillation. Circulation 2006; 114:2010.</a></li><li><a class="nounderline abstract_t">Mortensen K, Risius T, Schwemer TF, et al. Biphasic versus monophasic shock for external cardioversion of atrial flutter: a prospective, randomized trial. Cardiology 2008; 111:57.</a></li><li><a class="nounderline abstract_t">Niebauer MJ, Chung MK, Brewer JE, Tchou PJ. Reduced cardioversion thresholds for atrial fibrillation and flutter using the rectilinear biphasic waveform. J Interv Card Electrophysiol 2005; 13:145.</a></li><li><a class="nounderline abstract_t">Stiell IG, Walker RG, Nesbitt LP, et al. BIPHASIC Trial: a randomized comparison of fixed lower versus escalating higher energy levels for defibrillation in out-of-hospital cardiac arrest. Circulation 2007; 115:1511.</a></li><li><a class="nounderline abstract_t">Deale OC, Lerman BB. Intrathoracic current flow during transthoracic defibrillation in dogs. Transcardiac current fraction. Circ Res 1990; 67:1405.</a></li><li><a class="nounderline abstract_t">Dahl CF, Ewy GA, Ewy MD, Thomas ED. Transthoracic impedance to direct current discharge: effect of repeated countershocks. Med Instrum 1976; 10:151.</a></li><li><a class="nounderline abstract_t">Geddes LA, Tacker WA, Cabler P, et al. The decrease in transthoracic impedance during successive ventricular defibrillation trials. Med Instrum 1975; 9:179.</a></li><li><a class="nounderline abstract_t">Kerber RE, Grayzel J, Hoyt R, et al. Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation 1981; 63:676.</a></li><li><a class="nounderline abstract_t">Fumagalli S, Tarantini F, Caldi F, et al. Multiple shocks affect thoracic electrical impedance during external cardioversion of atrial fibrillation. Pacing Clin Electrophysiol 2009; 32:371.</a></li><li><a class="nounderline abstract_t">Sirna SJ, Kieso RA, Fox-Eastham KJ, et al. Mechanisms responsible for decline in transthoracic impedance after DC shocks. Am J Physiol 1989; 257:H1180.</a></li><li><a class="nounderline abstract_t">Kerber RE, Vance S, Schomer SJ, et al. Transthoracic defibrillation: effect of sternotomy on chest impedance. J Am Coll Cardiol 1992; 20:94.</a></li><li><a class="nounderline abstract_t">Ewy GA, Hellman DA, McClung S, Taren D. Influence of ventilation phase on transthoracic impedance and defibrillation effectiveness. Crit Care Med 1980; 8:164.</a></li><li><a class="nounderline abstract_t">Ewy GA, Taren D. Comparison of paddle electrode pastes used for defibrillation. Heart Lung 1977; 6:847.</a></li><li><a class="nounderline abstract_t">Crampton R. Accepted, controversial, and speculative aspects of ventricular defibrillation. Prog Cardiovasc Dis 1980; 23:167.</a></li><li><a class="nounderline abstract_t">Gascho JA, Crampton RS, Cherwek ML, et al. Determinants of ventricular defibrillation in adults. Circulation 1979; 60:231.</a></li><li><a class="nounderline abstract_t">Link MS, Atkins DL, Passman RS, et al. Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S706.</a></li><li><a class="nounderline abstract_t">Winkle RA, Stinson EB, Bach SM Jr, et al. Measurement of cardioversion/defibrillation thresholds in man by a truncated exponential waveform and an apical patch-superior vena caval spring electrode configuration. Circulation 1984; 69:766.</a></li><li><a class="nounderline abstract_t">Kienzle MG, Miller J, Falcone RA, et al. Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia. Circulation 1984; 70:957.</a></li><li><a class="nounderline abstract_t">Kerber RE, Kienzle MG, Olshansky B, et al. Ventricular tachycardia rate and morphology determine energy and current requirements for transthoracic cardioversion. Circulation 1992; 85:158.</a></li><li><a class="nounderline abstract_t">Windecker S, Ideker RE, Plumb VJ, et al. The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans. J Am Coll Cardiol 1999; 33:33.</a></li><li><a class="nounderline abstract_t">Dalzell GW, Adgey AA. Determinants of successful transthoracic defibrillation and outcome in ventricular fibrillation. Br Heart J 1991; 65:311.</a></li><li><a class="nounderline abstract_t">Winkle RA, Mead RH, Ruder MA, et al. Effect of duration of ventricular fibrillation on defibrillation efficacy in humans. Circulation 1990; 81:1477.</a></li><li><a class="nounderline abstract_t">Weaver WD, Cobb LA, Copass MK, Hallstrom AP. Ventricular defibrillation -- a comparative trial using 175-J and 320-J shocks. N Engl J Med 1982; 307:1101.</a></li><li><a class="nounderline abstract_t">Ricard P, Lévy S, Trigano J, et al. Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 1997; 79:815.</a></li><li><a class="nounderline abstract_t">Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967; 29:469.</a></li><li><a class="nounderline abstract_t">Echt DS, Black JN, Barbey JT, et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. Circulation 1989; 79:1106.</a></li><li><a class="nounderline abstract_t">Suddath WO, Deychak Y, Varghese PJ. Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation. Ann Emerg Med 2001; 38:201.</a></li><li><a class="nounderline abstract_t">Oral H, Souza JJ, Michaud GF, et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 1999; 340:1849.</a></li></ol></div><div id="topicVersionRevision">Topic 975 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13309666" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Termination of ventricular fibrillation in man by externally applied electric countershock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13931298" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13682369" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Use of external electric countershock in the treatment of ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Termination of refractory tachycardia by external countershock</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14484484" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : External electrical termination of supraventricular arrhythmias in congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3359585" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3624489" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Relationship between canine transthoracic impedance and defibrillation threshold. Evidence for current-based defibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6624665" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Determinants of defibrillation: prospective analysis of 183 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3170969" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Current-based versus energy-based ventricular defibrillation: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3713273" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Effect of microscopic and macroscopic discontinuities on the response of cardiac tissue to defibrillating (stimulating) currents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4828606" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Patterns of ventricular activity during catheter defibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2364513" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Mechanism of cardiac defibrillation in open-chest dogs with unipolar DC-coupled simultaneous activation and shock potential recordings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3949979" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Activation during ventricular defibrillation in open-chest dogs. Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1146696" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1860233" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Mechanism of cardiac defibrillation. A different point of view.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Currently known mechanisms underlying direct current external and internal cardiac defibrillation</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3698224" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2344664" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Comparison of activation during ventricular fibrillation and following unsuccessful defibrillation shocks in open-chest dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9286969" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Effects of transvenous electrode polarity and waveform duration on the relationship between defibrillation threshold and upper limit of vulnerability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2394014" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Ventricular refractory period extension caused by defibrillation shocks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2036724" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Prolongation of repolarization time by electric field stimulation with monophasic and biphasic shocks in open-chest dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10676690" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12475846" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Cardiac troponin T and cardiac enzymes after external transthoracic cardioversion of ventricular arrhythmias in patients with coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14118499" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : THE TECHNIQUE OF CARDIOVERSION.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10573502" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12414201" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12414196" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Electrode positioning for cardioversion of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36342151" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Defibrillation Strategies for Refractory Ventricular Fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7266602" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Elective cardioversion: influence of paddle-electrode location and size on success rates and energy requirements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10336913" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Randomised comparison of electrode positions for cardioversion of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15824079" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32007169" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/842442" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Effectiveness of direct current defibrillation: role of paddle electrode size.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/851067" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effectiveness of direct current defibrillation: role of paddle electrode size: II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2801525" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Electrode pad size, transthoracic impedance and success of external ventricular defibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4641071" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The interelectrode electrical resistance at defibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/634191" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Impedance to transthoracic direct current discharge: a model for testing interface material.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4430099" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7273381" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Determinants of intracardiac current in defibrillation. Experimental studies in dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15734772" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6744362" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Defibrillation of 100 kg calves with asymmetrical, bidirectional, rectangular pulses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9815877" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Relative efficacy of monophasic and biphasic waveforms for transthoracic defibrillation after short and long durations of ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10869271" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Resuscitation after prolonged ventricular fibrillation with use of monophasic and biphasic waveform pulses for external defibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6869564" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Improved defibrillator waveform safety factor with biphasic waveforms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10987622" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Monophasic versus biphasic transthoracic countershock after prolonged ventricular fibrillation in a swine model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11023932" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Optimized Response to Cardiac Arrest (ORCA) Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10551711" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Comparison of a novel rectilinear biphasic waveform with a damped sine wave monophasic waveform for transthoracic ventricular defibrillation. ZOLL Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10725288" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12084594" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15194019" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26904970" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Biphasic versus monophasic waveforms for transthoracic defibrillation in out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15992986" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Out-of-hospital cardiac arrest rectilinear biphasic to monophasic damped sine defibrillation waveforms with advanced life support intervention trial (ORBIT).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17060379" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Transthoracic incremental monophasic versus biphasic defibrillation by emergency responders (TIMBER): a randomized comparison of monophasic with biphasic waveform ascending energy defibrillation for the resuscitation of out-of-hospital cardiac arrest due to ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18239394" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Biphasic versus monophasic shock for external cardioversion of atrial flutter: a prospective, randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16133842" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Reduced cardioversion thresholds for atrial fibrillation and flutter using the rectilinear biphasic waveform.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17353443" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : BIPHASIC Trial: a randomized comparison of fixed lower versus escalating higher energy levels for defibrillation in out-of-hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2245502" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Intrathoracic current flow during transthoracic defibrillation in dogs. Transcardiac current fraction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1272089" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Transthoracic impedance to direct current discharge: effect of repeated countershocks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1143118" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The decrease in transthoracic impedance during successive ventricular defibrillation trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7460251" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19272068" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Multiple shocks affect thoracic electrical impedance during external cardioversion of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2801977" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Mechanisms responsible for decline in transthoracic impedance after DC shocks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1607545" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Transthoracic defibrillation: effect of sternotomy on chest impedance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7363632" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Influence of ventilation phase on transthoracic impedance and defibrillation effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/587701" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Comparison of paddle electrode pastes used for defibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7001540" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Accepted, controversial, and speculative aspects of ventricular defibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/445741" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Determinants of ventricular defibrillation in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20956222" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6697460" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Measurement of cardioversion/defibrillation thresholds in man by a truncated exponential waveform and an apical patch-superior vena caval spring electrode configuration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6499152" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1728445" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Ventricular tachycardia rate and morphology determine energy and current requirements for transthoracic cardioversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9935005" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2054239" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Determinants of successful transthoracic defibrillation and outcome in ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2331763" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Effect of duration of ventricular fibrillation on defibrillation efficacy in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7121527" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Ventricular defibrillation -- a comparative trial using 175-J and 320-J shocks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9070570" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6029120" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Electrical reversion of cardiac arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2469545" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11524637" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10369847" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
